| # | Drug | Count |
|---|---|---|
| 0 | ETANERCEPT | 86 |
| 1 | ADALIMUMAB | 75 |
| 2 | ACETAMINOPHEN | 57 |
| 3 | ASPIRIN | 57 |
| 4 | ASPIRIN 81 MG | 57 |
| 5 | ASPIRIN 325 MG | 56 |
| 6 | METHOTREXATE SODIUM | 51 |
| 7 | ERGOCALCIFEROL | 48 |
| 8 | OMEPRAZOLE MAGNESIUM | 48 |
| 9 | METHOTREXATE | 45 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | PHENAZOPYRIDINE HYDROCHLORIDE | 4 | 0.0121 |
| 1 | METHENAMINE, SODIUM PHOSPHATE, MONOBASIC, METHYLENE BLUE, AND HYOSCYAMINE SULFATE | 1 | 0.0090 |
| 2 | HYDROCORTISONE 2.5% | 1 | 0.0062 |
| 3 | FLUORIDE TOOTHPASTE | 1 | 0.0050 |
| 4 | EUCALYPTOL, MENTHOL, UNSPECIFIED FORM, METHYL SALICYLATE, AND THYMOL | 1 | 0.0045 |
| 5 | EFGARTIGIMOD ALFA AND HYALURONIDASE (HUMAN RECOMBINANT) | 2 | 0.0041 |
| 6 | INFLIXIMAB-DYYB | 12 | 0.0035 |
| 7 | NAFTIFINE HYDROCHLORIDE | 1 | 0.0030 |
| 8 | ACETAMINOPHEN, IBUPROFEN | 1 | 0.0027 |
| 9 | FLUPHENAZINE DECANOATE | 1 | 0.0023 |
| # | Drug class | Count |
|---|---|---|
| 0 | Tumor Necrosis Factor Blocker [EPC] | 144 |
| 1 | Nonsteroidal Anti-inflammatory Drug [EPC] | 119 |
| 2 | Corticosteroid [EPC] | 101 |
| 3 | Platelet Aggregation Inhibitor [EPC] | 58 |
| 4 | Benzodiazepine [EPC] | 54 |
| 5 | Proton Pump Inhibitor [EPC] | 51 |
| 6 | Provitamin D2 Compound [EPC] | 48 |
| 7 | Interleukin-23 Antagonist [EPC] | 46 |
| 8 | Folate Analog Metabolic Inhibitor [EPC] | 44 |
| 9 | HMG-CoA Reductase Inhibitor [EPC] | 41 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 9 | 0.0131 |
| 1 | Guanylate Cyclase-C Agonist [EPC] | 5 | 0.0024 |
| 2 | Provitamin D2 Compound [EPC] | 48 | 0.0016 |
| 3 | CD38-directed Cytolytic Antibody [EPC] | 8 | 0.0014 |
| 4 | Neonatal Fc Receptor Blocker [EPC] | 5 | 0.0011 |
| 5 | Endoglycosidase [EPC] | 2 | 0.0011 |
| 6 | Non-Standardized Fungal Allergenic Extract [EPC] | 2 | 0.0009 |
| 7 | Interleukin-17A Antagonist [EPC] | 30 | 0.0008 |
| 8 | Human Immunoglobulin G [EPC] | 14 | 0.0007 |
| 9 | Ester Local Anesthetic [EPC] | 23 | 0.0005 |